Shen Shan

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

Kenneth J. Valenzano, Laykea Tafesse, Gary Lee et al. · Neuropharmacology · 2005 · 282 citations

Cannabis Use, Molecular Pharmacology, Pain Research +12

Pharmacological characterization of recombinant N-type calcium channel (Cav2.2) mediated calcium mobilization using FLIPR

Elfrida R. Benjamin, Farhana Pruthi, Shakira Olanrewaju et al. · Biochemical Pharmacology · 2006 · 29 citations

Molecular Pharmacology, Pharmacological Characterization, Medicine +5

1,3-Dihydro-2,1,3-benzothiadiazol-2,2-diones and 3,4-dihydro-1H-2,1,3-benzothidiazin-2,2-diones as ligands for the NOP receptor

R. Richard Goehring, John F. Whitehead, Kevin Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 19 citations · Full text

Functional Selectivity, Medicine, Receptor (Biochemistry) +5

Design and parallel synthesis of piperidine libraries targeting the nociceptin (N/OFQ) receptor

Zhengming Chen, Wendy Miller, Shen Shan et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 18 citations · Full text

Piperidine Libraries, Medicinal Chemistry, Biochemistry +14

DiPOA ([8-(3,3-Diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic Acid), a Novel, Systemically Available, and Peripherally Restricted Mu Opioid Agonist with Antihyperalgesic Activity: I. In Vitro Pharmacological Characterization and Pharmacokinetic Properties

Kenneth J. Valenzano, Wendy Miller, Zhengming Chen et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 17 citations